SHIRE PHARMACEUTICALS GROUP PLC
S-3, EX-23.2, 2000-06-20
PHARMACEUTICAL PREPARATIONS
Previous: SHIRE PHARMACEUTICALS GROUP PLC, S-3, EX-23.1, 2000-06-20
Next: SHIRE PHARMACEUTICALS GROUP PLC, S-3, EX-23.3, 2000-06-20




                                                           Exhibit 23.2


                         Consent of Independent Auditors

         We consent to the reference to our firm under the caption  "Experts" in
the  Registration  Statement  on  Form  S-3  and  related  Prospectus  of  Shire
Pharmaceuticals  Group plc for the  registration  of  21,214,628 of its ordinary
shares  and to the  incorporation  by  reference  therein  of our  report  dated
February 16, 1999,  with respect to the  consolidated  financial  statements  of
Roberts  Pharmaceutical  Corporation  for the  year  ended  December  31,  1998,
included in the Shire  Pharmaceuticals Group plc Annual  Report on Form 10-K for
the year ended  December  31,  1999,  filed  with the  Securities  and  Exchange
Commission.

                                                    /s/ Ernst & Young LLP
MetroPark, New Jersey
June 16, 2000



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission